Everything you need to win Janet Hammond — in one platform.
Who to reach, what to say, and why now on Janet Hammond — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.
Get the full Deep Dive on Janet Hammond — free.
One free Deep Dive, emailed to you. No spam; unsubscribe anytime.
Enterprise Therapeutics announced the appointment of Dr Renu Gupta as CMO and Dr Janet Hammond as a Non-Executive Director. Dr Gupta brings over 20 years of experience in the biopharmaceutical industry, while Dr Hammond has over 20 years’ experience in the pharmaceutical industry, overseeing the development and successful approval of several drugs.
Company Information
Company
Enterprise Therapeutics Ltd
Location
Brighton, England, United Kingdom
About
Enterprise Therapeutics is a drug discovery company dedicated to the research and development of novel therapies for the treatment of respiratory diseases.
In diseases such as cystic fibrosis, asthma and COPD the lungs become congested with mucus leading to difficulty in breathing. New disease modifying therapies that target the underlying mechanisms of mucus congestion will reduce the frequency of lung infections and improve patient quality of life.
The leadership team has significant expertise in drug discovery, drug development, respiratory biology and ion channel pharmacology. The company benefits from a close working relationship with the School of Life Sciences at the University of Sussex.